SCHEMBL5128903

SCHEMBL5128903

Cc1[nH]nc2c1c(=O)n(CCCNCc1ccncc1)c1cc3c(cc21)CCCC3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 11/20 0.47
KCNH2 Q12809 2/20 0.47
AURKA O14965 1/20 0.36
KDR P35968 1/20 0.36
AURKB Q96GD4 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 3/20 0.33
NOD2 Q9HC29 1/20 0.33
NOD1 Q9Y239 1/20 0.33
KDM4E B2RXH2 2/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PDE6D O43924 1/20 0.33
PDE6A P16499 1/20 0.33
PDE6G P18545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5128848 0.92 CHEK1 (0.48) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5122777 0.91 CHEK1 (0.47) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5129462 0.90 CHEK1 (0.44) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5132167 0.88 CHEK1 (0.49) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5128290 0.86 CHEK1 (0.45) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5129114 0.84 CHEK1 (0.47) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5126029 0.82 CHEK1 (0.51) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5123881 0.81 CHEK1 (0.55) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5125899 0.80 CHEK1 (0.55) CHEK1KCNH2AURKAKDRAURKB
SCHEMBL5132330 0.80 CHEK1 (0.68) CHEK1KCNH2AURKAKDRAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US claimed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114016-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, BUB1B CHEK1 1/4885KCNH2 3426/4885AURKA 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.